Febrile Neutropenia
📧 Sign up to get email alerts when something new happens for Febrile Neutropenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-19Clinical Trial Update: Patient Preference Between a Prefilled Syringe or a Prefilled Pen Device for Administration of Pegfilgrastim
A completed clinical trial compared patient preferences between a prefilled syringe and a prefilled pen for administering pegfilgrastim.
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: Antimicrobial Revision in Persistent Febrile Neutropenia [Phase 4]
A Phase 4 clinical trial evaluating an antimicrobial revision for persistent febrile neutropenia has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-08-12Clinical Trial Update: Antibiotics Management of Septic Neutropenic Patients in the Intensive Care Unit
Clinical trial update indicating that the study on antibiotics management for septic neutropenic patients in the Intensive Care Unit has com…
-
CLINICAL_TRIALS research · 2024-07-17Clinical Trial Update: Short Antibiotic Treatment in High Risk Febrile Neutropenia [NA]
Clinical trial update shows a study evaluating a short antibiotic treatment strategy for high-risk febrile neutropenia is currently recruiti…
-
CLINICAL_TRIALS trial_result · 2024-07-11Clinical Trial Update: Adjustment of Antibiotic Dosage in Pediatric Oncology Patients With Febrile Neutropenia and Augmented Renal Clearance [Phase 4]
Phase 4 Clinical Trial update evaluating adjustment of antibiotic dosing in pediatric oncology patients with febrile neutropenia and augment…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-06-24Clinical Trial Update: Metagenomic Sequencing for the Identification of Pathogens in Febrile Neutropenic Patients [NA]
Clinical trial investigating metagenomic sequencing to identify pathogens in febrile neutropenic, immunocompromised patients with hematologi…
-
CLINICAL_TRIALS research · 2024-06-10Clinical Trial Update: PROSpECT-PRIOR-2-CHEMO: PRIOR Dental Intervention Before Chemo to Reduce Chemotherapy Complications [NA]
This trial update describes PROSpECT-PRIOR-2-CHEMO, a study evaluating a prior dental intervention before chemotherapy to reduce chemotherap…
-
CLINICAL_TRIALS trial_result · 2024-03-08Clinical Trial Update: Stopping Antibiotics After 3 Days for the Treatment of High-risk FEbrile Neutropenia [Phase 4]
A Phase 4 trial investigating stopping antibiotics after 3 days for high-risk febrile neutropenia.
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Early Neutropenic Fever De-escalation of Antibiotics Study [Phase 3]
Phase 3 trial exploring de-escalation of antibiotics for early neutropenic fever in hematologic malignancy.
-
FDA approval · 2023-10-13FDA Approved: FULPHILA — Supplemental Application (Biocon Biologics Inc.)
FDA approved a supplemental Biologics License Application for FULPHILA (pegfilgrastim-jmdb) by Biocon Biologics Inc.
-
FDA approval · 2023-10-12FDA Approved: PIPERACILLIN AND TAZOBACTAM — Original Application (Eugia US LLC)
FDA approved the original abbreviated new drug application for piperacillin and tazobactam, a combination antibiotic manufactured by Eugia U…
-
CLINICAL_TRIALS trial_result · 2023-09-14Clinical Trial Update: A Trial of Fosfomycin vs Ciprofloxacin for Febrile Neutropenia [Phase 3]
Phase 3 trial comparing fosfomycin to ciprofloxacin for febrile neutropenia is in progress with unknown status.
-
CLINICAL_TRIALS trial_result · 2023-08-15Clinical Trial Update: Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer [Phase 1, Phase 2]
A clinical trial update on managing severe chemotherapy-induced neutropenia in advanced breast cancer, completed phases 1 and 2.
-
CLINICAL_TRIALS trial_result · 2022-10-20Clinical Trial Update: S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) [NA]
Clinical trial update for S1415CD (TrACER) reporting completed status with results posted; study involves CSF prescribing effectiveness and …
-
CLINICAL_TRIALS withdrawal · 2022-03-31Clinical Trial Update: Amoxicillin-clavulanate Alone or in Combination With Ciprofloxacin in Low-Risk Febrile Neutropenic Adult Patients: A Prospective, Double-blind, Randomized, Non-Inferiority Multicenter, Phase III Clinical Trial. [Phase 3]
Phase III trial evaluating amoxicillin-clavulanate alone or with ciprofloxacin in low-risk febrile neutropenia; study status withdrawn.
-
FDA approval · 2022-03-18FDA Approved: CEFEPIME HYDROCHLORIDE AND DEXTROSE — Supplemental Application (B. Braun Medical Inc.)
FDA approved a supplemental application for Cefepime hydrochloride and dextrose from B. Braun Medical Inc.
-
CLINICAL_TRIALS trial_result · 2021-07-08Clinical Trial Update: Feasibility of Monitoring Health Data in Pediatric Patients Undergoing Chemotherapy
Completed feasibility trial evaluating monitoring of health data in pediatric patients undergoing chemotherapy.
-
FDA approval · 2021-03-16FDA Approved: PIPERACILLIN AND TAZOBACTAM — Supplemental Application (Eugia US LLC)
The FDA approved a supplemental application for Piperacillin and Tazobactam (piperacillin sodium and tazobactam sodium) submitted by Eugia U…
-
CLINICAL_TRIALS trial_result · 2021-02-12Clinical Trial Update: Efficacy of Extended Infusion of β-lactam Antibiotics for the Treatment of Febrile Neutropenia in Hematologic Patients [Phase 4]
Phase 4 trial assessing the efficacy of extended infusion beta-lactam antibiotics for febrile neutropenia in hematologic patients.
-
CLINICAL_TRIALS trial_result · 2019-12-06Clinical Trial Update: Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever [Phase 4]
A Phase 4 clinical trial comparing cefepime to ceftazidime as empirical therapy for neutropenic fever has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-06Clinical Trial Update: Various G-CSF Regimens to Prevent Infection During Chemotherapy [Phase 3]
Phase 3 trial update evaluating various G-CSF regimens to prevent infection in chemotherapy for breast cancer.
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer [Phase 3]
Phase 3 trial update evaluating Granulocyte Colony Stimulating Factor for prevention of febrile neutropenia in epithelial ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2019-09-25Clinical Trial Update: Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUO [Phase 4]
A Phase 4 clinical trial compared short versus extended antibiotic treatment with a carbapenem for high-risk febrile neutropenia in hematolo…
-
FDA approval · 2019-05-29FDA Approved: FULPHILA — Supplemental Application (Biocon Biologics Inc.)
FDA approved a supplemental application for Fulphila (pegfilgrastim-jmdb) from Biocon Biologics Inc., expanding its regulatory status.
-
FDA approval · 2019-04-16FDA Approved: UDENYCA — Supplemental Application (Accord BioPharma, Inc.)
FDA approved a supplemental application for UDENYCA (pegfilgrastim-cbqv) from Accord BioPharma, authorizing a new or expanded use for the pr…